Press
Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning

Resources

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Announcement

Culture Biosciences Establishes Advisory Board Of Biotech And Biopharma Executives To Guide The Corporate Strategy And Accelerate Growth

June 1, 2023
Announcement
Press

Surfing the Waves in Upstream Bioprocess Development – Molecule to Market Podcast with Culture’s CEO, Will Patrick

May 5, 2023
Press
Case study

Significant CHOZN® Titer Gains: How MilliporeSigma Leveraged Nexxys and Culture’s Cloud Bioreactor Platform

April 4, 2023
Case study
Announcement

Culture Biosciences Focuses Technology And Service Platform On Biologics

March 14, 2023
Announcement
Product update

InSiliCHO: Modeling Cell Line Dynamics for Process Development

February 24, 2023
Product update
Product update

Launching Culture’s 5L Reactors: An Interview with CEO Will Patrick

September 14, 2022
Product update
Case study

Making Bioengineering a Reality: Culture Enables Sestina’s New SynBio Platform

January 21, 2022
Case study
Announcement

Culture Biosciences Raises $80m Series B To Tackle Demand For Large-Scale Biomanufacturing

October 14, 2021
Announcement
Case study

Why Joyn Bio Won’t Build a High-Throughput Fermentation Lab

March 5, 2021
Case study
Subscribe to our newsletter
Blog

Latest resources

Press

Culture Biosciences Announces Close of Series C Round to Accelerate Commercial Growth of Stratyx 250 and Console Platform

December 16, 2025
Press

Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning

December 9, 2025